Search results for #AACR24
Unlock the potential of #ExtracellularVesicles (EVs) #Proteomics for non-invasive cancer monitoring! Delve into our #AACR24 collaboration with Nexosome Oncology, where our #TrueDiscovery® services revealed cancer-specific biomarkers in EVs. More: ow.ly/23mf50RsknU
In this interview from #AACR24, Shawn Levy from @ElemBio talks about #AVITI24, their new multiomics platform that can provide deeper insights into cancer biology. biotechniques.com/molecular-biol…
Congratulations, Angela B. Mariotto, @DrRobinYabroff, and colleagues, on the CEBP Frederick P. Li Impact Award! @DrRobinYabroff is pictured with Editor-in-Chief Elizabeth Platz. Learn more: bit.ly/3QnYeZC @AmericanCancer #AACR24
Thank you @CCR_AACR great to be able to meet Dr Flaherty and @Marlowe_Tessmer at #AACR24 @MSK_DeptOfMed
Thank you @CCR_AACR great to be able to meet Dr Flaherty and @Marlowe_Tessmer at #AACR24 @MSK_DeptOfMed
Congratulations to Steven A. Rosenberg, MD, PhD, and colleagues, recipients of the inaugural Cancer Immunology Research Award for Outstanding Journal Article! Learn more about this award: bit.ly/3UCe6u1 #AACR24
Geoff Chong, MD, of @ONJCancerCentre, shared data on odronextamab, a novel bispecific antibody in #follicularlymphoma, presented at #AACR24! Watch his interview here ➡️ buff.ly/44hseMx
Congratulations, Denise Cecil, PhD, on the Cancer Prevention Research Award for Outstanding Journal Article! Dr. Cecil is pictured with Jing Peng, PhD (@JingPeng123), and Michael Pollak, MD. Learn more: bit.ly/4aWLBwH @UWCancerVaccine #CancerPrevention #AACR24
#AACR24: First-in-Class Compounds Target MIEN1 Pathway, Have Potential Therapeutic Use: jnccn360.org/prostate/news/… #JNCCN360 #PCSM #prostatecancer
Congratulations, @UrviShahMD, on the inaugural Clinical Cancer Research Early Career Award! Dr. Shah is pictured with Editor-in-Chief Keith Flaherty and Executive Editor @Marlowe_Tessmer. Learn more: bit.ly/4bkw7CN @MSKCancerCenter #AACR24
Looking forward to our special session tomorrow 4/30 3pmPT/6pmET! @AdvocateCollab members @ARosen380, @tambreleighn, @paspears88, and @EugeneManley will be sharing their #AACR24 roles & perspectives as poster presenters, session moderators, SSP mentors, SSP participants, and more
🎥@docchristoffer highlights the promising immunotherapeutic landscape for melanoma, discussing the INTerpath-001 trial's combinatory approach with neoantigen therapies and pembrolizumab: ➡️ow.ly/hKv850Rr8FA⬅️ #AACR24 #ImmunoOnc
Join us on May 22 for a thought-provoking discussion at our Fireside chat after #AACR24. Expert perspectives on the latest #SpatialBiology trends and decoding cancer insights will be shared. Register: bit.ly/3UAts2g #AACR2024 #SpatialBiology @AACR @aruthak @GENbio
And a part of that #AACR24 fun is that I got a chance to present a collaborative study on mutational landscapes in the lung in a minisymposium. Many thanks to our collaborators at @CUAnschutz and in the UK @TheMarkFdn @lcrf_org @CRUKLungCentre @RosetreesT @RuthStraussFdn
Big THANKS to @AACR, #MICR, #WICR, and funders for making it possible for me to present our work, network with great scientists, and learn from people of incredible character at #AACR24. I am grateful for those who have invested in me and my vision. #InADreamICouldntHaveDreamt
#AACR24 was a whirlwind of exciting breakthroughs like activating the immune system to fight cancer through #Immunotherapy Advancements like these play a crucial role in offering patients a fighting chance. Explore our approach in #oncology: curadev.in/immune-oncology
Florida Cancer Specialists & Research Institute Clinical Research Driving Progress to Cure Cancer @LucioGordanMD @CesarAPerezMD @AACR #AACR24 #bcsm #pcsm https://www.onclive/com/view/florida-cancer-specialists-research-institute-clinical-research-driving-progress-to-cure-cancer
ICYMI: @DanaFarber's Kornelia Polyak, MD, PhD, who received the 2023 @AACR Distinguished Lectureship in Breast Cancer Research, explored age-related mammary gland changes in her #AACR24 plenary session. ➡️ https:/dfci.widen.net/s/pgc8mq7m8v/aacr-annual-meeting-presentations-2024
At #AACR24, @skopetz, of @MDAndersonNews, shared data on using adagrasib plus cetuximab in patients with metastatic colorectal cancer harboring KRAS G12C mutations. #crcsm #oncology onclive.com/view/dr-kopetz…
